Post Profile






A New Blood Test Approach can Assess Levels of Amyloid-? in the Brain

Researchers have developed a blood test that correlates well with levels of amyloid-? in the brain, offering an opportunity to reduce the cost of assessing potential therapies to treat Alzheimer's disease. Currently the only reliable methods are invasive or expensive, requiring access to cerebrospinal fluid or the use of scanning technologies. This work might be considered in the broader context of a range of studies linking amyloid-? in blood vessels and bloodstream with amyloid-? in the brain; it is thought that the relationship between amyloid-? inside and outside the brain may be a two-way street, a form of equilibrium.
read more

share

Related Posts


Heart medications may help treat Alzheimer’s disease by reducing plaque buildup in the brain’s blood vessels

Health : Bel Marra Health

Heart medications may help treat Alzheimer’s disease by reducing plaque buildup in the brain’s blood vessels. Researcher Prof. Magnus Grenegård explained, “You should be careful not to draw any major conclusions from experimental st...

Reducing Amyloid Beta Levels in a Mouse Model of Alzheimer's

Health / Aging : Fight Aging

This is one of a number of approaches in recent years that has significantly reduced the levels of amyloid beta in the brain in the mouse version of Alzheimer's disease used for research. As for the others, it remains to be seen whe...

Gantenerumab Reduces Amyloid Levels In Alzheimer's Disease Patients

Health : Medical News Today

Patients with Alzheimer's disease who were given experimental medication gantenerumab experienced reductions in brain amyloid levels, researchers from Roche, Switzerland, reported in the journal Archives of Neurology. The authors st...

New Insight on Why People with Down Syndrome Invariably Develop Alzheimer's Disease

Health : Newswise Medical News

Researchers discover the cell events in the brains of individuals with Down syndrome that lead to the amyloid pathology observed in the brains of patients with Alzheimer's disease. The findings support a novel approach to treating a...

Blood test identifies key Alzheimer's marker

Health / Aging : ScienceDaily: Healthy Aging

Measures of amyloid beta in the blood have the potential to help identify people with altered levels of amyloid in their brains or cerebrospinal fluid, new research shows. Currently, the only way to detect amyloid beta in the brain ...

Comments


Copyright © 2016 Regator, LLC